Loading company…
ID 405232207 · FY 2019–2024 · 6 years
კომპანიის ძირითად საქმიანობას წარმოადგენს მედიკამენტებით და სამედიცინო სახარჯი მარაგებით საბითუმო ვაჭრობა.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 2,459 | 2,629 | 5,678 | 6,596 | 4,700 | 4,724 | +14.0% |
| Total COGS | -1,129 | -1,338 | -3,132 | -4,346 | -3,135 | -3,251 | +23.6% |
| Gross Profit | 1,330 | 1,291 | 2,546 | 2,250 | 1,565 | 1,474 | +2.1% |
| Gross Margin | 54.1% | 49.1% | 44.8% | 34.1% | 33.3% | 31.2% | |
| Total Operating Expenses | -279 | -390 | -308 | -667 | -799 | -872 | +25.6% |
| EBITDA | 1,051 | 901 | 2,238 | 1,583 | 766 | 602 | -10.5% |
| EBITDA Margin | 42.7% | 34.3% | 39.4% | 24.0% | 16.3% | 12.7% | |
| Total D&A | -2 | -4 | -3 | -3 | -18 | -15 | +45.0% |
| EBIT / Operating Income | 1,049 | 897 | 2,234 | 1,580 | 748 | 587 | -11.0% |
| Total Interest Income | 0 | 0 | 0 | 0 | 11 | 29 | +159.3% |
| Total Interest Expense | 0 | 0 | 0 | -19 | -1 | 0 | -93.8% |
| Total Other Income | -5 | -19 | 27 | 222 | -13 | -27 | +37.9% |
| Profit Before Tax | 1,043 | 878 | 2,262 | 1,784 | 746 | 589 | -10.8% |
| Total Income Tax | -45 | -63 | -154 | -174 | -170 | -108 | +19.3% |
| Net Profit / (Loss) | 999 | 815 | 2,108 | 1,610 | 575 | 482 | -13.6% |
| Net Margin | 40.6% | 31.0% | 37.1% | 24.4% | 12.2% | 10.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.